Fair Value Calculator Fair Value Calculator
EN DE

MCCHRLS-B Fair Value & Analysis

IN · Market cap ₹9.2B

MB MCCHRLS-B MCCHRLS-B · BSE
Price₹699.00
Fair Value₹218.18
Upside-68.8%
Quality38/100
Watch MCCHRLS-B for free, get notified when fair value or trend changes. Watch for free
Evidence: Medium Range ₹97.94 – ₹376.89 📤 Share as image

Fair value as of: Jul 8, 2026

From 8 valuation models · updated 13 days ago

Share price +0.6% over the past month.

Price vs Fair Value (12 months)

₹740.80 ₹551.30 Fair Value ₹218.18 Jul 2025 Jul 2026

12‑month range ₹551.30 – ₹740.80 · fair‑value band ₹97.94 – ₹376.89 · the ₹699.00 price screens above the ₹218.18 fair value. As of Jul 8, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

MCCHRLS-B (MCCHRLS-B) currently trades at ₹699.00, while our model-based Fair Value estimate is ₹218.18, implying the stock looks roughly 68.8% overvalued today. We read business quality at 38/100 (below-average quality). Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: medium).

Trailing-twelve-month revenue stands at ₹1.1B. Net debt stands at ₹15.0B. Fundamentals as of Jul 8, 2026

Our scenario range runs from ₹97.94 (bear case) to ₹376.89 (bull case); at ₹699.00, the current price sits above that range. The share trades about 11% below its 52-week high and 37% above its 52-week low, currently above its 200-day average.

Key figures & financial health

Revenue (TTM) ₹1.1B
Revenue growth (YoY) +1,567%
Net margin -105%
Return on equity -253%
Free cash flow −₹2.0B FY2026
Operating margin 59.1%
More key figures
EPS (TTM) ₹-88.76
Net debt ₹15.0B FY2026

Figures from reported company fundamentals (EODHD) · as of Jul 8, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

MCCHRLS-B reported revenue of ₹1.1B in FY2026 versus ₹106M in FY2022, a compound +79.8%/yr. Reported net income was −₹1.2B in FY2026.

Revenue +79.8%/yr
FY22 ₹106M
FY23 ₹108M
FY24 ₹112M
FY25 ₹98.3M
FY26 ₹1.1B
Net income
FY22 ₹1.1B
FY23 ₹426M
FY24 −₹662M
FY25 −₹1.1B
FY26 −₹1.2B

Is MCCHRLS-B fairly valued? → Check now

📤 Share or link this analysis
🔗 Embed on your site (free fair-value badge)

Paste this into your site or blog, it shows the current fair value and links back here (free, and welcome):

Cite: Fair Value Calculator (2026). "MCCHRLS-B Fair Value". https://www.fairvalue-calculator.com/stock/MCCHRLS-B

Explore undervalued stocks

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is MCCHRLS-B undervalued?
As of Jul 8, 2026, our model estimates a fair value of ₹218.18 versus a price of ₹699.00, about −69% (overvalued). Model-based estimate, not financial advice.
What is the fair value of MCCHRLS-B?
Our model-based fair value for MCCHRLS-B is ₹218.18 (as of Jul 8, 2026), built from audited fundamentals. The current price is ₹699.00.
What is the quality score of MCCHRLS-B?
MCCHRLS-B has a Quality Score of 38/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of MCCHRLS-B?
MCCHRLS-B reported trailing-twelve-month revenue of about ₹1.1B (latest available figure, as of Jul 8, 2026).
What is the net profit margin of MCCHRLS-B?
The net profit margin of MCCHRLS-B is about -105.4%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Unlock the full MCCHRLS-B analysis, and try Pro free

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.

Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.